Navigation Links
Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material
Date:10/8/2009

NANTONG CITY, China, Oct. 8 /PRNewswire-Asia-FirstCall/ -- Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) ("Sinobiopharma") (the "Company") is pleased to announce that the Company received a certificate for the use of Gabexate mesylate as a pharmaceutical raw material (Certificate #2009S01805) from the Chinese State Food and Drug Administration ("SFDA").

Gabexate Mesylate is a serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

The Company is now awaiting GMP certification to manufacture Gabexate mesylate.

About Sinobiopharma

Sinobiopharma, Inc. is a fully integrated and highly innovative specialty biopharmaceutical company engaged in the research and development, manufacture and marketing of biopharmaceutical products in China, the world's fastest growing pharmaceutical market. Known as Dong Ying (Jiangsu) Pharmaceutical Co., Ltd. in China, the Company's current therapeutic focus is on anesthesia-assisted agents and cardiovascular drugs.

FORWARD LOOKING STATEMENTS

This news release may include "forward-looking statements" regarding Sinobiopharma, Inc., and its subsidiaries, business and project plans. Such forward looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor created by such sections. Where Sinobiopharma, Inc. expresses or implies an expectation or belief as to future events or results, such expectation or belief is believed to have a reasonable basis. However, forward-looking statements are subject to risks, uncertainties and other f
'/>"/>

SOURCE Sinobiopharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray
2. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
3. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
4. Chinese SFDA Grants Immtech Fast Track Status
5. Tainted Chinese Food Ingredients First Discovered in 2005
6. United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food
7. Regence to Cover Administration Costs of H1N1 Vaccine for Fully-Insured Groups, Individuals This Flu Season
8. Food and Drug Administration Accepts Isolagens Biologics License Application for Full Review
9. U.S. Food and Drug Administration Clears Way for Multi-Center Clinical Trial of IDEV Technologies SUPERA Peripheral Stent
10. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
11. Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015 Henry Schein, Inc. (NASDAQ: ... products and services to office-based dental, animal health and ... quarter ended March 28, 2015. Net sales ... an increase of 1.4% compared with the first quarter ... currencies and a 6.0% decline related to foreign currency ...
(Date:5/4/2015)...  Verus Healthcare, Inc. recently completed its third year ... in 2012.  Since that original acquisition, the Company has ... (DME) industry by 1,000%.  Verus Healthcare now services approximately ... and processes nearly 14,000 new orders per month. ... the systems and processes weren,t in place to scale," ...
(Date:5/4/2015)...  NeuroSigma ® , Inc. (NeuroSigma), a California ... animal study of its Thin Film Nitinol (TFN) flow diverter ... researchers at the 53 rd Annual Meeting of the ... . A copy of the study abstract can be accessed ... at Mayo Clinic was primarily funded through a Small Business ...
Breaking Medicine Technology:Henry Schein Reports Record First Quarter Results 2Henry Schein Reports Record First Quarter Results 3Henry Schein Reports Record First Quarter Results 4Henry Schein Reports Record First Quarter Results 5Henry Schein Reports Record First Quarter Results 6Henry Schein Reports Record First Quarter Results 7Henry Schein Reports Record First Quarter Results 8Henry Schein Reports Record First Quarter Results 9Henry Schein Reports Record First Quarter Results 10Henry Schein Reports Record First Quarter Results 11Henry Schein Reports Record First Quarter Results 12Henry Schein Reports Record First Quarter Results 13Henry Schein Reports Record First Quarter Results 14Henry Schein Reports Record First Quarter Results 15Henry Schein Reports Record First Quarter Results 16Henry Schein Reports Record First Quarter Results 17Verus Healthcare Celebrates 1,000% Growth on Third Anniversary 2NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 2NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 3NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 4
... Dec. 13, 2011 /PRNewswire-Asia/ -- Bristol-Myers Squibb Company ... Pharmaceutical Group (NYSE: SCR ), a ... companies have expanded the strategic partnership formed last year ... area. The companies agreed to co-develop BMS-795311, Bristol-Myers Squibb,s ...
...  BioMed Realty Trust, Inc. (NYSE: BMR ) ... agreement to acquire Prudential Real Estate Investors, (PREI) 80% ... a 20% interest in the properties in April 2007 ... and PREI.  The Rogers Street properties are located in ...
Cached Medicine Technology:Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound 2Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound 3Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound 4Biomed Realty Trust to Acquire Remaining 80% Interest in Rogers Street Properties in Cambridge, Massachusetts for $308 Million - Increasing Ownership to 100% 2Biomed Realty Trust to Acquire Remaining 80% Interest in Rogers Street Properties in Cambridge, Massachusetts for $308 Million - Increasing Ownership to 100% 3Biomed Realty Trust to Acquire Remaining 80% Interest in Rogers Street Properties in Cambridge, Massachusetts for $308 Million - Increasing Ownership to 100% 4
(Date:5/4/2015)... Pricing Healthcare announces it will ... patient receiving care at St. George Surgical Center ... be performed by July 15th, 2015, and the patient must ... front and forego the filing of insurance claims). , The ... year, and it devastates more and more individuals and families. ...
(Date:5/4/2015)... 2015 San Diego Fertility Center ... their brand new, 13,700 square foot facility scheduled to ... will not only provide fertility treatment and services for ... community and educational events to a number of local ... next door to their current Carmel Valley/Del Mar location ...
(Date:5/4/2015)... 04, 2015 Sheltering Arms announced that ... Hale House. The Mother Hale Learning Center meets a ... Childhood Education. Sheltering Arms will begin operating the site ... served by the center. , Opened in 2006, the ... weeks to five years, many of whom come from ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Dr. Benjamin ... Georgia proudly offers the latest non-surgical double-chin eliminator. ... facial plastic surgeon in Atlanta to offer Kybella ... to be injected specifically under the chin, promising to ... , Before Kybella, patients who sought immediate solutions for ...
(Date:5/4/2015)... New West Medicare is excited to announce ... manage outpatient advanced imaging services for its members. Care ... members are provided the right test at the right ... New West Medicare’s physicians and hospitals, Care to Care ... imaging and provide an objective basis for informed evidence-based ...
Breaking Medicine News(10 mins):Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:Sheltering Arms Acquires the Mother Hale Learning Center 2Health News:Facial Plastic Surgeon First in Atlanta To Offer Kybella Treatments To Reduce Chin Fat 2Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2
... a fair distribution of bird flu vaccines, the World ... stockpile of vaccines// for developing countries. ,The global ... fight against avian influenza, WHO director general Margaret Chan ... ,Chan met President Susilo Bambang Yudhoyono Wednesday ...
... one million children under the age of five lose ... ,Considering the fact that these deaths are ... vaccine that addresses seven different strains of pneumococcal diseases ... ,Pneumococcal diseases, which affect the lungs, brain and the ...
... older population may soon be facing a medical care crisis ... rapidly//, say researchers at the University of Cincinnati. ... be more than 70 million people over the age of ... data collected over the last decade, the number of certified ...
... breast cancer who are treated with both chemotherapy ... patients who receive only tamoxifen//. But a combination ... ovaries from functioning—did not show any additional benefits, ... ,Survival rates improve for patients with ...
... Mediterranean diet could help protect children from respiratory allergies and ... and Spanish researchers assessed the diet and health of almost ... conditions are rare. ,Crete is the largest ... Mediterranean Sea. ,Researchers found those children reared on ...
... drugs during a recent influenza B epidemic in Japan ... the drugs//, according to a study. ,Two ... of drugs known as neuraminidase inhibitors, have been effective ... documented evidence of the emergence of oseltamivir-resistant type A ...
Cached Medicine News:Health News:Number of Students Taking Up Geriatric Medicine on the Decline 2Health News:Combining Therapies can Improve Survival for Early-stage Breast Cancer Patients 2Health News:Fruit and Vegetable Diet 'could Prevent Asthma' 2Health News:Study Suggests Some Drug Resistance to Influenza B Medications 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: